News

CLINICAL TRIALS LIST

The clinical trials list has been updated. See list on this link

Posted September 14, 2016

pCODR Expert Review Committee (pERC) Final Recommendation for Nivolumab in Advanced Kidney Cancer

The Health Technology Assessment review for nivolumab for advanced kidney cancer has concluded with a recommendation that nivolumab be reimbursed, conditional on pending price negotiations with the manufacturer. The pCODR recommendation provides guidance for all provinces except Quebec. pCODR report on this link.

Posted September 2, 2016

COLLECTIVE WISDOM: KIDNEY CANCER UPDATES FROM ASCO 2016

See our latest blog for highlights on the American Society of Clinical Oncology (ASCO) meeting held in Chicago from June 3 to June 7. Read blog on this link

Posted June 22, 2016

Events

MARK YOUR CALENDARS!
Upcoming Patient Education Meetings

KIDNEY CANCER IN NEWFOUNDLAND & LABRADOR
TWO LOCATIONS:
ST. JOHN'S & EASTPORT
Friday, September 23, 2016
10 am - 12 pm NDT
Details & registration on this link

 

MONTREAL, QUEBEC
Kidney Cancer Treatment & Emerging Therapies
Wednesday, October 5, 2016
7 - 9 pm EDT
(meeting will be held in French)
Details & registration on this link

 

Latest Tweets

The Canadian Urological Association (CUA) endorses Kidney Cancer Canada and its mission; this does not necessarily equate to endorsement of this website's contents.
LinkedIn Google Plus Twitter Facebook Youtube Instagram Wordpress